A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
ITM Solucin GmbH
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
University of Cincinnati
University College, London
Molecular Insight Pharmaceuticals, Inc.